Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol by Allan.

Slides:

Advertisements

Similar presentations

Break the Fast: “Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control.

Advertisements

Information on Competitive Products For investor use only; not to be used for other purposes. v

Slide Source: Lipids Online Slide Library High-Density Lipoprotein and the Epidemiology of Coronary Heart Disease Michael Miller,

Cholesterol Lipid Component of cell membrane Found in the diet – Eggs, dairy, liver High levels lead to development of CHD 2 types of cholesterol -carrying.

Clinical Trial Results. org Value of Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and Women:

Risk factors in heart disease Optimizing patient care

Blood samples available from study participants with myocardial infarction and controls by ethnic origin Matthew J McQueen, et al. Lancet 2008; 372:

* Plus–minus values are means ±SD. † Race was determined by the investigator. ‡ The body-mass index is the weight in kilograms divided by the square of.

Lipoproteins Clusters of lipids associated with proteins that serve as transport vehicles for lipids in the lymph and blood.

Lipoproteins/Particles

Glynn RJ, et al. N Engl J Med 2009 Mar 29 [Epub ahead of print]

Table 1. Cluster 1 Patients Attaining Treatment Levels % Patients Attaining Treatment Levels 24 Weeks64 Weeks E/S + N † E/S † N†N† E/S + N † E/S † Cluster.

Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:

Non-HDL Cholesterol and Apo B: To B or Not to B? 非高密度脂蛋白胆固醇与载脂蛋白 B ：选用载脂蛋白 B 吗？ Dr Richard Pang 3 November (Thursday) 2005 Symposium on Laboratory Medicine.

Baseline Characteristics of Cases, Controls, and Entire VA-HIT Population James D. Otvos, et al, Circulation 2006;113:

Metabolic syndrome from a gender and cardiovascular perspective Eva Swahn.

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer.

ASSOCIATION OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WITH INCIDENT CARDIOVASCULAR EVENTS IN WOMEN, BY LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN.

The balance between apoB and apoA-I, i.e. the apoB/apoA-I ratio, indicates cardiovascular risk; the higher the ratio, the higher is the risk G. Walldius.

Parish S, et al. Eur Heart J 2009 [Epub ahead of print]

Ridker PM, et al. Lancet 2009;373: Baseline clinical characteristics of the study population in the placebo and rosuvastatin groups according.

Trial profile Prakash Deedwania, et al. Lancet 2006; 368:

Trends in Diabetes Incidence: The Framingham Heart Study Featured Article: Tobin M. Abraham, Karol M. Pencina, Michael J. Pencina, and Caroline S. Fox.

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2013 ACC/AHA Guideline on the Treatment of Blood.

Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Varespladib and Cardiovascular Events in Patients.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Lipid Profile, Plasma Apolipoproteins, and Risk of.

Date of download: 6/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Major Lipids, Apolipoproteins, and Risk of Vascular.

Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL.

Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Test in Context: High-Sensitivity C-Reactive Protein.

Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Application of the Screening for Heart Attack Prevention.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implications of Coronary Artery Calcium Testing.

Apolipoproteins as markers and managers of coronary risk by D.C. Chan, and G.F. Watts QJM Volume 99(5): April 24, 2006 © The Author Published.

Should we move from Lipids to Lipoproteins, from Dyslipidemia to Dyslipoproteinemia in future guidelines for CVD?

Percentage of Community-Dwelling Adults Ages 18 and Older Who Had Their Blood Cholesterol Checked Within the Past Five Years, 1998 and 2003 Data: National.

2013 ACC/AHA cholesterol treatment guidelines

Obesity Trends* Among U.S. Adults BRFSS, 1985

Olli T. Raitakari, Ville-Petteri Mäkinen, Matthew J

Copyright © 2012 American Medical Association. All rights reserved.

American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular.

Objectively Measured Sedentary Time and Cardiovascular Risk Factor Control in US Hispanics/Latinos With Diabetes Mellitus: Results From the Hispanic Community.

Serum Total 25‐OH Vitamin D Adds Little Prognostic Value in Patients Undergoing Coronary Catheterization by Michael E. Gerling, Matthew T. James, Stephen.

Association of blood lipids with AF

Insulin Resistance as an Independent Risk Factor for Carotid Wall Thickening by Masaaki Suzuki, Kazuya Shinozaki, Akio Kanazawa, Yasushi Hara, Yuichi Hattori,

Dyslipidemia and the Risk of Developing Hypertension in a Working‐Age Male Population by Toshiaki Otsuka, Hirotaka Takada, Yasuhiro Nishiyama, Eitaro Kodani,

Long‐Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening by Kasper Aalbæk Kjærgaard, Morten.

Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh,

Behavior and Biology: The Basic Sciences for AHA Action

by John T. Wilkins, Hongyan Ning, Neil J. Stone, Michael H

Prediction of Cardiovascular Disease by the Framingham‐REGICOR Equation in the High‐Risk PREDIMED Cohort: Impact of the Mediterranean Diet Across Different.

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Figure 7 Mendelian randomization of overlapping exposures

Charles R. Harper, MD, Terry A. Jacobson, MD Mayo Clinic Proceedings

Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology by Mary Cushman,

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Charles R. Harper, MD, Terry A. Jacobson, MD Mayo Clinic Proceedings

Reevaluation by High-Performance Liquid Chromatography: Clinical Significance of Microalbuminuria in Individuals at High Risk of Cardiovascular Disease.

If triglycerides matter, why do they matter?

2013 ACC/AHA cholesterol treatment guidelines

Hajer GR et al. Atherosclerosis 2009;202:216-24

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

Per-Ola Attman, M.D, Petar Alaupovic, Ola Samuelsson

Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA/EDEN trials Allan D. Sniderman, MD, James A. Sloand,

Volume 67, Issue 4, Pages (April 2005)

Receiver operating curves (ROC) of simple age and gender adjusted risk factor models for predicting 10-year risk of cardiovascular disease comparing the.

Benefit from Earlier Intervention

Increase of physical activity over time associated with lower HF risk

Determinants of moderate Cardiovascular Health Index Score (CHIS) (achieving three or more risk factor targets). Determinants of moderate Cardiovascular.

Calculating the overall accuracy in different samples using the V-plot

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Forest plot showing survival c-statistics for selected models, applied to the testing cohort. Forest plot showing survival c-statistics for selected models,

Presentation transcript:

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol by Allan D. Sniderman, Shofiqul Islam, Matthew McQueen, Michael Pencina, Curt D. Furberg, George Thanassoulis, and Salim Yusuf J Am Heart Assoc Volume 5(10):e003665 October 13, 2016 © 2016 Allan D. Sniderman et al.

Odds ratios for low‐density lipoprotein cholesterol (LDL‐C), non‐high‐density lipoprotein cholesterol (non‐HDL‐C), and apolipoprotein B (apoB) overall and for each decade. Odds ratios for low‐density lipoprotein cholesterol (LDL‐C), non‐high‐density lipoprotein cholesterol (non‐HDL‐C), and apolipoprotein B (apoB) overall and for each decade. Allan D. Sniderman et al. J Am Heart Assoc 2016;5:e003665 © 2016 Allan D. Sniderman et al.

Odds ratios for high‐density lipoprotein cholesterol (HDL‐C) and apolipoprotein A‐1 (apoA‐I) overall and for each decade. Odds ratios for high‐density lipoprotein cholesterol (HDL‐C) and apolipoprotein A‐1 (apoA‐I) overall and for each decade. Allan D. Sniderman et al. J Am Heart Assoc 2016;5:e003665 © 2016 Allan D. Sniderman et al.